Stock Code: China Resources Sanjiu Medical & Pharmaceutical Co.Ltd(000999) stock abbreviation: China Resources Sanjiu Medical & Pharmaceutical Co.Ltd(000999) No.: 2022020
China Resources Sanjiu Medical & Pharmaceutical Co.Ltd(000999)
Insiders and incentive objects of restricted stock incentive plan in 2021
Self inspection report on trading company shares
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
China Resources Sanjiu Medical & Pharmaceutical Co.Ltd(000999) (hereinafter referred to as ” China Resources Sanjiu Medical & Pharmaceutical Co.Ltd(000999) ” or “the company”, “the company”) held the 12th meeting of the board of directors in 2021 and the 9th meeting of the board of supervisors in 2021 on December 1, 2021, deliberated and adopted the company’s 2021 restricted stock incentive plan (Draft) and its summary and other relevant proposals. See the company’s website on December 2021 for details（ http://www.cn.info.com.cn. ）And announcements published in China Securities Journal and securities times.
In accordance with the measures for the administration of equity incentive of listed companies (hereinafter referred to as “the measures”), the guidelines for the business handling of listed companies of Shenzhen Stock Exchange No. 9 – equity incentive (hereinafter referred to as “the guidelines”) and other relevant laws and regulations, as well as the articles of association and other relevant provisions, The company has taken sufficient and necessary confidentiality measures for the 2021 restricted stock incentive plan (hereinafter referred to as the “incentive plan”) and made necessary registration for the insiders of the incentive plan. Through Shenzhen Branch of China Securities Depository and Clearing Corporation Limited (hereinafter referred to as “CSDCC”), the company inquired about the insider information of the incentive plan and the purchase and sale of the company’s shares by the incentive objects within 6 months before the public disclosure of the draft incentive plan (i.e. from June 1, 2021 to December 1, 2021, hereinafter referred to as the “self inspection period”), The details are as follows:
1、 Verification scope and procedure
1. The verification object is the insider of the incentive plan and the incentive object (hereinafter referred to as the “verification object”);
2. The insiders of this incentive plan have filled in the registration form of insiders of inside information;
3. The company inquired with CSDCC about the purchase and sale of the company’s shares during the self inspection period, and CSDCC issued the inquiry certificate of shareholding and share change of information disclosure obligor and the detailed list of shareholder share change.
2、 The verification object bought and sold the company’s shares during the self inspection period
According to the inquiry certificate on Shareholding and share change of information disclosure obligors and the detailed list of shareholder share change issued by China Clearing on December 10, 2021, during the self-examination period, insiders did not buy or sell the company’s shares, and 41 incentive objects bought or sold the company’s shares. According to the written statement issued by the above incentive object, the company’s stock trading during the self inspection period is based on its own judgment on the trading situation of the secondary market, which has nothing to do with the equity incentive. Before buying and selling the company’s shares, it did not know the specific information of the incentive plan, nor did any person disclose it to it Disclose the relevant information of the incentive plan or suggest them to buy and sell the company’s shares based on this, and there is no case of using insider information for stock trading.
3、 Verification conclusion
In conclusion, through self-examination, the company has taken corresponding confidentiality measures in strict accordance with relevant regulations in the process of planning and demonstrating the incentive plan, limited the scope of participants, and registered relevant personnel and intermediaries who have access to insider information in time. Within 6 months before the public disclosure of the draft incentive plan, no insider or incentive object has been found to use the insider information of the incentive plan to buy and sell the company’s shares, which complies with the relevant provisions of the administrative measures and the handling guide No. 9, and there is no insider trading.
4、 Documents for future reference
1. Inquiry certificate of shareholding and share change of information disclosure obligor issued by Shenzhen Branch of China Securities Depository and Clearing Co., Ltd;
2. Detailed list of changes in shareholders’ shares issued by Shenzhen Branch of China Securities Depository and Clearing Corporation Limited. It is hereby announced
China Resources Sanjiu Medical & Pharmaceutical Co.Ltd(000999) board of directors
March 3, 2002
